ViaLase
PrivateLast Round
Series C
Apr 1, 2024
Total Funding Raised
$75.4M
Company Overview
ViaLase is a medical technology company that develops a non-invasive, image-guided femtosecond laser surgical system for the treatment of open-angle glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViaLase Comparables
Compare ViaLase with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bausch + Lomb Corporation | 73% | |
| Iantrek | 73% | |
| Avisi Technologies Inc. | 72% |
ViaLase Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 1, 2024 | ||||
| Seed | Jan 18, 2024 | ||||
| Series B | Nov 1, 2021 | ||||
| Series A | Apr 1, 2019 |
Key People
Founding team and executive leadership
ViaLase Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arboretum Ventures | Series C, Series B |
| Venture Investors Health Fund | Series C |
| Venture Investors LLC | Seed, Series B, Series A |
| Falcon Vision | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Presenting new scientific research at the 2026 ARVO Annual Meeting.
- Jan 18, 2024
$2.3M raised in Seed round.
ViaLase Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ViaLase's valuation, stock price, and market status.
Is ViaLase a public or private company?
ViaLase is a private company.
What is the current stock price of ViaLase?
ViaLase is a private company with no public stock price. No recent secondary market data is available.
How much is ViaLase worth (valuation)?
Valuation information for ViaLase is not publicly available.
Can I buy ViaLase stock?
ViaLase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ViaLase's last funding round?
ViaLase's most recent funding round was Series C on April 1, 2024.
Who are the main investors in ViaLase?
Key investors in ViaLase include Falcon Vision.
Will ViaLase IPO soon?
No public IPO plans have been announced for ViaLase.
How can I track ViaLase secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ViaLase's secondary market activity and sign up for updates.